東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

The Impact of the Regulatory Environ...

Grant, Kelly.

FindBook

Google Book

Amazon

博客來

The Impact of the Regulatory Environment on Entry Mode Choice: Empirical Evidence from the Pharmaceutical Industry.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	The Impact of the Regulatory Environment on Entry Mode Choice: Empirical Evidence from the Pharmaceutical Industry./
作者:	Grant, Kelly.
出版者:	Ann Arbor : ProQuest Dissertations & Theses, : 2024,
面頁冊數:	80 p.
附註:	Source: Dissertations Abstracts International, Volume: 85-06, Section: B.
Contained By:	Dissertations Abstracts International85-06B.
標題:	Pharmacology. -
電子資源:	https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30818872
ISBN:	9798381170023

The Impact of the Regulatory Environment on Entry Mode Choice: Empirical Evidence from the Pharmaceutical Industry.
Grant, Kelly.

The Impact of the Regulatory Environment on Entry Mode Choice: Empirical Evidence from the Pharmaceutical Industry. - Ann Arbor : ProQuest Dissertations & Theses, 2024 - 80 p.

Source: Dissertations Abstracts International, Volume: 85-06, Section: B.

Thesis (Ph.D.)--Southern New Hampshire University, 2024.

This item must not be sold to any third party vendors.

One of the contemporary strategic management challenges of pharmaceutical firm internationalization is the firm's inability to simultaneously launch new products across multiple markets due to differences in the procedures and requirements of regulatory agencies. Often, the requirements for new drug applications are explicitly stated by the regulatory agencies in each market. However, there are also unstated factors that could influence the entry mode choices of pharmaceutical firms as they expand abroad.Pharmaceutical firms that operate in complex regulatory environments develop tacit knowledge from navigating regulations within their home market, potentially making themselves attractive to foreign firms wanting to enter the market quickly. This dissertation analyzes the influence of the procedural characteristics of the pharmaceutical firm regulatory agencies in host market on foreign direct investment entry mode choice. A logistic regression analysis is used to assess whether markets with more arduous regulatory requirements lend themselves to a merger and acquisition strategy over a greenfield venture strategy. The findings showed that the procedural characteristics of pharmaceutical regulatory agencies in host countries were not statistically significant but showed a high predictive value for greenfield ventures. However, the firm's level of host country experience and the difference in the corruption perception index scores of home and host countries both added significantly to the entry mode prediction. The results provide insight into pharmaceutical firms as they engage in foreign direct investment activities.

ISBN: 9798381170023Subjects--Topical Terms:

634543
Pharmacology.
Subjects--Index Terms:

Entry mode choice

The Impact of the Regulatory Environment on Entry Mode Choice: Empirical Evidence from the Pharmaceutical Industry.
LDR:02977nmm a2200409 4500 001 2395446
005 20240517100629.5
006 m o d
007 cr#unu||||||||
008 251215s2024 ||||||||||||||||| ||eng d
020 $a 9798381170023
035 $a (MiAaPQ)AAI30818872
035 $a AAI30818872
040 $a MiAaPQ $c MiAaPQ
100 1 $a Grant, Kelly. $3 3764952
245 1 0 $a The Impact of the Regulatory Environment on Entry Mode Choice: Empirical Evidence from the Pharmaceutical Industry.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2024
300 $a 80 p.
500 $a Source: Dissertations Abstracts International, Volume: 85-06, Section: B.
500 $a Advisor: Aybar, Bulent.
502 $a Thesis (Ph.D.)--Southern New Hampshire University, 2024.
506 $a This item must not be sold to any third party vendors.
520 $a One of the contemporary strategic management challenges of pharmaceutical firm internationalization is the firm's inability to simultaneously launch new products across multiple markets due to differences in the procedures and requirements of regulatory agencies. Often, the requirements for new drug applications are explicitly stated by the regulatory agencies in each market. However, there are also unstated factors that could influence the entry mode choices of pharmaceutical firms as they expand abroad.Pharmaceutical firms that operate in complex regulatory environments develop tacit knowledge from navigating regulations within their home market, potentially making themselves attractive to foreign firms wanting to enter the market quickly. This dissertation analyzes the influence of the procedural characteristics of the pharmaceutical firm regulatory agencies in host market on foreign direct investment entry mode choice. A logistic regression analysis is used to assess whether markets with more arduous regulatory requirements lend themselves to a merger and acquisition strategy over a greenfield venture strategy. The findings showed that the procedural characteristics of pharmaceutical regulatory agencies in host countries were not statistically significant but showed a high predictive value for greenfield ventures. However, the firm's level of host country experience and the difference in the corruption perception index scores of home and host countries both added significantly to the entry mode prediction. The results provide insight into pharmaceutical firms as they engage in foreign direct investment activities.
590 $a School code: 0363.
650 4 $a Pharmacology. $3 634543
650 4 $a Finance. $3 542899
653 $a Entry mode choice
653 $a Establishment mode
653 $a Foreign direct investment
653 $a Greenfield investment
653 $a Pharmaceutical industry
653 $a Regulatory uncertainty
690 $a 0454
690 $a 0419
690 $a 0508
710 2 $a Southern New Hampshire University. $b International Business. $3 3285569
773 0 $t Dissertations Abstracts International $g 85-06B.
790 $a 0363
791 $a Ph.D.
792 $a 2024
793 $a English
856 4 0 $u https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30818872